Symmetric Dimethylarginine Is Not Associated with Cumulative Inflammatory Load or Classical Cardiovascular Risk Factors in Rheumatoid Arthritis: A 6-Year Follow-Up Study
Symmetric dimethylarginine (SDMA) indirectly inhibits nitric oxide (NO) synthesis and predicts cardiovascular and all-cause mortality in high-risk patients. The aim of our study was to investigate the associations of cumulative inflammatory burden (assessed by serial measurements of inflammatory mar...
Saved in:
Main Authors: | Theodoros Dimitroulas, James Hodson, Aamer Sandoo, Jacqueline P. Smith, Karen M. Douglas, George D. Kitas |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2015/796562 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of Three Sample Preparation Procedures for the Quantification of L-Arginine, Asymmetric Dimethylarginine, and Symmetric Dimethylarginine in Human Plasma Using HPLC-FLD
by: Anne Marie Voigt Schou-Pedersen, et al.
Published: (2018-01-01) -
Genetic Markers of Cardiovascular Disease in Rheumatoid Arthritis
by: Luis Rodríguez-Rodríguez, et al.
Published: (2012-01-01) -
Risk of Cardiovascular Diseases in Diabetes Mellitus and Serum Concentration of Asymmetrical Dimethylarginine
by: Seema L. Jawalekar, et al.
Published: (2013-01-01) -
Serum Symmetric Dimethylarginine as an Early Marker of Excretory Dysfunction in Canine Leishmaniosis (L. infantum) Induced Nephropathy
by: Esther Torrent, et al.
Published: (2018-01-01) -
Tocilizumab modulates the activity of the classical and alternative complement pathways in rheumatoid arthritis patients
by: Iván Ferraz-Amaro, et al.
Published: (2025-01-01)